634 related articles for article (PubMed ID: 32852623)
21. Esophageal manometric findings in autoimmune rheumatic diseases: is scleroderma esophagus a specific entity?
Tsianos EB; Drosos AA; Chiras CD; Moutsopoulos HM; Kitridou RC
Rheumatol Int; 1987; 7(1):23-7. PubMed ID: 3495853
[TBL] [Abstract][Full Text] [Related]
22. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
Misra DP; Agarwal V; Gasparyan AY; Zimba O
Clin Rheumatol; 2020 Jul; 39(7):2055-2062. PubMed ID: 32277367
[TBL] [Abstract][Full Text] [Related]
23. [Cardiac involvement in systemic autoimmune disease].
Dropiński J; Szczeklik W; Rubiś P
Pol Arch Med Wewn; 2003 Apr; 109(4):375-81. PubMed ID: 12931489
[TBL] [Abstract][Full Text] [Related]
24. Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
Winthrop KL; Weinblatt ME; Bathon J; Burmester GR; Mease PJ; Crofford L; Bykerk V; Dougados M; Rosenbaum JT; Mariette X; Sieper J; Melchers F; Cronstein BN; Breedveld FC; Kalden J; Smolen JS; Furst D
Ann Rheum Dis; 2020 Jan; 79(1):88-93. PubMed ID: 31662322
[TBL] [Abstract][Full Text] [Related]
25. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity.
Sardu C; Cocco E; Mereu A; Massa R; Cuccu A; Marrosu MG; Contu P
PLoS One; 2012; 7(3):e32487. PubMed ID: 22396771
[TBL] [Abstract][Full Text] [Related]
26. The clinical application of etanercept in Chinese patients with rheumatic diseases.
Chou CT
Mod Rheumatol; 2006; 16(4):206-13. PubMed ID: 16906369
[TBL] [Abstract][Full Text] [Related]
27. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.
Kastritis E; Kitas GD; Vassilopoulos D; Giannopoulos G; Dimopoulos MA; Sfikakis PP
Rheumatol Int; 2020 Sep; 40(9):1353-1360. PubMed ID: 32654078
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Bozzalla Cassione E; Zanframundo G; Biglia A; Codullo V; Montecucco C; Cavagna L
Ann Rheum Dis; 2020 Oct; 79(10):1382-1383. PubMed ID: 32398281
[No Abstract] [Full Text] [Related]
29. Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies.
Ferri C; Raimondo V; Gragnani L; Giuggioli D; Dagna L; Tavoni A; Ursini F; L'Andolina M; Caso F; Ruscitti P; Caminiti M; Foti R; Riccieri V; Guiducci S; Pellegrini R; Zanatta E; Varcasia G; Olivo D; Gigliotti P; Cuomo G; Murdaca G; Cecchetti R; De Angelis R; Romeo N; Ingegnoli F; Cozzi F; Codullo V; Cavazzana I; Colaci M; Abignano G; De Santis M; Lubrano E; Fusaro E; Spinella A; Lumetti F; De Luca G; Bellando-Randone S; Visalli E; Bosco YD; Amato G; Giannini D; Bilia S; Masini F; Pellegrino G; Pigatto E; Generali E; Mariano GP; Pettiti G; Zanframundo G; Brittelli R; Aiello V; Caminiti R; Scorpiniti D; Ferrari T; Campochiaro C; Brusi V; Fredi M; Moschetti L; Cacciapaglia F; Paparo SR; Ragusa F; Mazzi V; Elia G; Ferrari SM; Di Cola I; Vadacca M; Lorusso S; Monti M; Lorini S; Aprile ML; Tasso M; Miccoli M; Bosello S; D'Angelo S; Doria A; Franceschini F; Meliconi R; Matucci-Cerinic M; Iannone F; Giacomelli R; Salvarani C; Zignego AL; Fallahi P; Antonelli A
Curr Pharm Des; 2022; 28(24):2022-2028. PubMed ID: 35726427
[TBL] [Abstract][Full Text] [Related]
30. Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review.
Grange L; Guilpain P; Truchetet ME; Cracowski JL;
Therapie; 2020; 75(4):335-342. PubMed ID: 32665090
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy.
Quartuccio L; Valent F; Pasut E; Tascini C; De Vita S
Joint Bone Spine; 2020 Oct; 87(5):439-443. PubMed ID: 32445935
[TBL] [Abstract][Full Text] [Related]
32. Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
Broten L; Aviña-Zubieta JA; Lacaille D; Joseph L; Hanly JG; Lix L; O'Donnell S; Barnabe C; Fortin PR; Hudson M; Jean S; Peschken C; Edworthy SM; Svenson L; Pineau CA; Clarke AE; Smith M; Bélisle P; Badley EM; Bergeron L; Bernatsky S
J Rheumatol; 2014 Apr; 41(4):673-9. PubMed ID: 24584928
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome in rheumatological diseases.
Pereira RM; de Carvalho JF; Bonfá E
Autoimmun Rev; 2009 Mar; 8(5):415-9. PubMed ID: 19168158
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Gonzalez-Gonzalez V; Beltran-Aguilar VM; Arias-Peralta AG; De Avila-Gonzalez N; Guajardo-Jauregui N
Clin Rheumatol; 2023 Oct; 42(10):2677-2690. PubMed ID: 36627529
[TBL] [Abstract][Full Text] [Related]
35. COVID-19 in Italian patients with rheumatic autoimmune systemic diseases.
Ferri C; Giuggioli D; Raimondo V; Fallahi P; Antonelli A;
Ann Rheum Dis; 2023 Sep; 82(9):e211. PubMed ID: 33055077
[No Abstract] [Full Text] [Related]
36. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series.
Metyas S; Chen C; Aung T; Ballester A; Cheav S
Curr Rheumatol Rev; 2022; 18(4):346-351. PubMed ID: 35152867
[TBL] [Abstract][Full Text] [Related]
37. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
38. Early, Incomplete, or Preclinical Autoimmune Systemic Rheumatic Diseases and Pregnancy Outcome.
Spinillo A; Beneventi F; Locatelli E; Ramoni V; Caporali R; Alpini C; Albonico G; Cavagnoli C; Montecucco C
Arthritis Rheumatol; 2016 Oct; 68(10):2555-62. PubMed ID: 27158919
[TBL] [Abstract][Full Text] [Related]
39. Shared familial aggregation of susceptibility to autoimmune diseases.
Hemminki K; Li X; Sundquist K; Sundquist J
Arthritis Rheum; 2009 Sep; 60(9):2845-7. PubMed ID: 19714648
[No Abstract] [Full Text] [Related]
40. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
